Last update:

Immunology news

Immunology

Patient-driven discovery reveals potential target for autoimmune diseases

A medical mystery served as the genesis for a Yale-led study that has promising implications for treating a range of autoimmune diseases.

Oncology & Cancer

Scientists develop potential stealth cancer therapy

Sneaking by cancer's defenses, by disguising tumor-fighting antibodies inside the molecules cancer uses to nourish tumor growth, is the basis of a novel therapy from Yale Cancer Center researchers at the Yale School of Medicine ...

Oncology & Cancer

Study reveals dual role of protein in cancer treatment

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response, offering ...

Immunology

Protein may hold key to heart transplant tolerance

Northwestern Medicine investigators have uncovered how a protein contributes to heart transplant tolerance in mice, according to a study published in the Proceedings of the National Academy of Sciences.

Oncology & Cancer

New antibody harbors great potential for fighting blood cancer

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occurs in adults, is caused by malignantly degenerated precursor cells of certain white blood cells (B-cell precursors ...

Oncology & Cancer

The current state of immunotherapy in colorectal cancer

Colorectal cancer (CRC) is a major health concern worldwide, characterized by high incidence and mortality rates. Despite advances in treatment, metastatic CRC (mCRC) remains particularly challenging.

Neuroscience

Vaccination may reduce memory loss from COVID-19 infections

Since the outset of the COVID-19 pandemic, 10 to 30% of the general population has experienced some form of virus-induced cognitive impairment, including trouble concentrating, brain fog or memory loss. This led a team of ...

Oncology & Cancer

Understanding the mechanism behind melanoma resistance to treatment

In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team from UZH and USZ has now discovered that a factor secreted by tumor cells is responsible for the resistance. These findings ...